| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |